Literature DB >> 25201911

Role of miR-195 in aortic aneurysmal disease.

Anna Zampetaki1, Rizwan Attia2, Ursula Mayr2, Renata S M Gomes2, Alkystis Phinikaridou2, Xiaoke Yin2, Sarah R Langley2, Peter Willeit2, Ruifang Lu2, Bruce Fanshawe2, Marika Fava2, Javier Barallobre-Barreiro2, Chris Molenaar2, Po-Wah So2, Abeera Abbas2, Marjan Jahangiri2, Matthew Waltham2, Rene Botnar2, Alberto Smith2, Manuel Mayr1.   

Abstract

RATIONALE: Abdominal aortic aneurysms constitute a degenerative process in the aortic wall. Both the miR-29 and miR-15 families have been implicated in regulating the vascular extracellular matrix.
OBJECTIVE: Our aim was to assess the effect of the miR-15 family on aortic aneurysm development. METHODS AND
RESULTS: Among the miR-15 family members, miR-195 was differentially expressed in aortas of apolipoprotein E-deficient mice on angiotensin II infusion. Proteomics analysis of the secretome of murine aortic smooth muscle cells, after miR-195 manipulation, revealed that miR-195 targets a cadre of extracellular matrix proteins, including collagens, proteoglycans, elastin, and proteins associated with elastic microfibrils, albeit miR-29b showed a stronger effect, particularly in regulating collagens. Systemic and local administration of cholesterol-conjugated antagomiRs revealed better inhibition of miR-195 compared with miR-29b in the uninjured aorta. However, in apolipoprotein E-deficient mice receiving angiotensin II, silencing of miR-29b, but not miR-195, led to an attenuation of aortic dilation. Higher aortic elastin expression was accompanied by an increase of matrix metalloproteinases 2 and 9 in mice treated with antagomiR-195. In human plasma, an inverse correlation of miR-195 was observed with the presence of abdominal aortic aneurysms and aortic diameter.
CONCLUSIONS: We provide the first evidence that miR-195 may contribute to the pathogenesis of aortic aneurysmal disease. Although inhibition of miR-29b proved more effective in preventing aneurysm formation in a preclinical model, miR-195 represents a potent regulator of the aortic extracellular matrix. Notably, plasma levels of miR-195 were reduced in patients with abdominal aortic aneurysms suggesting that microRNAs might serve as a noninvasive biomarker of abdominal aortic aneurysms.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  aneurysm; biological markers; extracellular matrix; microRNAs; myocytes, smooth muscle

Mesh:

Substances:

Year:  2014        PMID: 25201911     DOI: 10.1161/CIRCRESAHA.115.304361

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  43 in total

Review 1.  Understanding the pathogenesis of abdominal aortic aneurysms.

Authors:  Helena Kuivaniemi; Evan J Ryer; James R Elmore; Gerard Tromp
Journal:  Expert Rev Cardiovasc Ther       Date:  2015

Review 2.  Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis.

Authors:  Mingyi Wang; Soo Hyuk Kim; Robert E Monticone; Edward G Lakatta
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

Review 3.  Non-coding RNAs: key regulators of smooth muscle cell fate in vascular disease.

Authors:  Nicholas J Leeper; Lars Maegdefessel
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

Review 4.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

5.  Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects.

Authors:  Tamas Kiss; Cory B Giles; Stefano Tarantini; Andriy Yabluchanskiy; Priya Balasubramanian; Tripti Gautam; Tamas Csipo; Ádám Nyúl-Tóth; Agnes Lipecz; Csaba Szabo; Eszter Farkas; Jonathan D Wren; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2019-08-28       Impact factor: 7.713

6.  Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.

Authors:  Dong Zheng; Jian Ma; Yong Yu; Minghui Li; Rui Ni; Grace Wang; Ruizhen Chen; Jianmin Li; Guo-Chang Fan; James C Lacefield; Tianqing Peng
Journal:  Diabetologia       Date:  2015-05-21       Impact factor: 10.122

Review 7.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

8.  Battle of the bulge: miR-195 versus miR-29b in aortic aneurysm.

Authors:  Joshua M Spin; Philip S Tsao
Journal:  Circ Res       Date:  2014-10-24       Impact factor: 17.367

Review 9.  Abdominal aortic aneurysm: novel mechanisms and therapies.

Authors:  Frank M Davis; Debra L Rateri; Alan Daugherty
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

10.  IGF-1 deficiency in a critical period early in life influences the vascular aging phenotype in mice by altering miRNA-mediated post-transcriptional gene regulation: implications for the developmental origins of health and disease hypothesis.

Authors:  Stefano Tarantini; Cory B Giles; Jonathan D Wren; Nicole M Ashpole; M Noa Valcarcel-Ares; Jeanne Y Wei; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.